Sign in

NCT07020299Completed

Effect of Electrical Diaphragmatic Stimulation on Chronic Obstructive Pulmonary Disease

Effect of Trans-cutenuous Electrical Diaphragmatic Stimulation on Severe Chronic Obstructive Pulmonary Disease Exacerbation

Source: ClinicalTrials.gov · Last updated 18 Aug 2026

Brief summary (registry, in English)

Respiratory muscle dysfunction is a common consequence of chronic obstructive pulmonary disease (COPD). This technique consists of placing electrodes on the skin at locations near the motor points of the diaphragm, transmitting an intermittent current, and generating action potentials capable of producing muscle contractions

Status (registry)
Completed
Study type
Interventional
Enrollment
128 (actual)
First submitted
27 May 2025
Start date
1 Aug 2024
Primary completion date
1 Feb 2025
Lead sponsor
Mansoura University Hospital
Diseases
COPD
NCT number
NCT07020299

What you commit to

  • Study type: Interventional
  • Participants enrolled: 128
  • From 1 Aug 2024 to the primary completion date, 1 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients on maintenance steroid therapy

Other illness

  • Lung disease other than COPD
  • History of neuromuscular disease at admission
  • Depletating disease as malignancy 14. Patients refusing the procedure

Other

  • Body mass index (BMI) \> 35 kg/m2
  • Post arrest patients
  • Brain death
  • Hemodynamic instability
  • Invasive MV
  • Pregnancy , ascitis.
  • Spinal injuries
  • Skin lesions or an open lesion in the regions where the electrodes would be placed
  • Use of pacemakers

Who the study is looking for

  • Age \>18 years.
  • Known cases of COPD admitted at respiratory critical care unit with severe acute exacerbation (defined according to GOLD 2024).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Medicine, Mansoura University
Coordinator of this site? Confirm its status
Al MansurahEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.